Table 4 Residual disease based on pathological findings
From: Chemoradiation with adjuvant hysterectomy for stage IB-2 cervical cancer: a 10-year experience
Residual disease | Total patients (n = 35) | Alive patients (%) | Deceased patients (%) | Treatment: number of patients (% of patients treated) |
|---|---|---|---|---|
Central (cervix/vaginal) | 22 | 21 (95) | 1 (5)a | Chemo = 8/22 (36.4) |
Vaginal brachytherapy = 1/22 (4.5) | ||||
Central and nodal | 7 | 0 (0) | 7 (100) | Chemo = 3/7 (42.9) |
Chemo/radiation = 3/7 (42.9) | ||||
Nodal | 4 | 1 (25) | 3 (75) | Chemo = 2/4 (50) |
Chemo/radiation = 2/4 (50) | ||||
Nonviable tumorb | 2 | 1 (50) | 1 (50) | Chemo = 1/2 (50) |